| AF-EEMS | Autofluorescence Excitation–Emission Matrix Scanner |
| AGE | Advanced glycation end product |
| ANA | Antinuclear antibody |
| AnuA | Anti-nucleosome antibody |
| Anti-dsDNA | Anti-double stranded DNA antibody |
| Anti-Ro60 | Anti-protein Ro60 antibody |
| Anti-Sm | Anti-Smith antibody |
| AU | Arbitrary units |
| C4 | Complement 4 |
| CI | Confidence interval |
| CRP | C reactive protein |
| CV | Cardiovascular |
| CVD | Cardiovascular disease |
| DM | Diabetes mellitus |
| eGFR | Estimated glomerular filtration rate |
| ELISA | Enzyme-linked immunosorbent assay |
| HC | Healthy control |
| IL-6 | Interleukin 6 |
| NR | Not reported |
| PGA | Physician global assessment |
| PtGA | Patient global assessment |
| RA | Rheumatic arthritis |
| SAF | Skin autofluorescence |
| SDI | SLE damage index |
| SLE | Systemic lupus erythematosus |
| SLEDAI | SLE disease activity index |
| sRAGE | Soluble receptor for advanced glycation end products |
| UVA | Ultraviolet-A radiation |